chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Sore right arm; Sored upoto her neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore right arm) and NECK PAIN (Sored upoto her neck) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore right arm) and NECK PAIN (Sored upoto her neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Jan-2021, NECK PAIN (Sored upoto her neck) had resolved. On 21-Jan-2021, PAIN IN EXTREMITY (Sore right arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment details-patient took Tylenol on 20 Jan 2021.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Hives appeared within 90 minutes of receiving the vaccine; Horrible rash all over his body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives appeared within 90 minutes of receiving the vaccine) and RASH (Horrible rash all over his body) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced URTICARIA (Hives appeared within 90 minutes of receiving the vaccine) and RASH (Horrible rash all over his body). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives appeared within 90 minutes of receiving the vaccine) and RASH (Horrible rash all over his body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   Treatment information mentioned stated methylprednisolone for one week.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Felt soreness in injection site on the day of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Felt soreness in injection site on the day of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Felt soreness in injection site on the day of injection). At the time of the report, VACCINATION SITE PAIN (Felt soreness in injection site on the day of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment and concomitant medications were reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: red blotch 2 in X 2 in. around the the injection site; injection site bump; injection site was tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site was tender), VACCINATION SITE MASS (injection site bump) and VACCINATION SITE ERYTHEMA (red blotch 2 in X 2 in. around the the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 1. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site was tender) and VACCINATION SITE MASS (injection site bump). On 17-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red blotch 2 in X 2 in. around the the injection site). On 16-Jan-2021, VACCINATION SITE PAIN (injection site was tender) and VACCINATION SITE MASS (injection site bump) outcome was unknown. At the time of the report, VACCINATION SITE ERYTHEMA (red blotch 2 in X 2 in. around the the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment medication was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itching at the injection arm; Redness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site erythema, Vaccination site induration
Clinical narrative: Arm pain; Injection site red; induration at the injection site; Headache; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm pain), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE INDURATION (induration at the injection site) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE INDURATION (induration at the injection site) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Arm pain), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE INDURATION (induration at the injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness on the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness on the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness on the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Computerised tomogram, Hypertension, Vision blurred
Clinical narrative: blurred vision; joints hurt; High pressure (went up repeatedly); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (High pressure (went up repeatedly)), VISION BLURRED (blurred vision) and ARTHRALGIA (joints hurt) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure since an unknown date.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced HYPERTENSION (High pressure (went up repeatedly)). On an unknown date, the patient experienced VISION BLURRED (blurred vision) and ARTHRALGIA (joints hurt). At the time of the report, HYPERTENSION (High pressure (went up repeatedly)) had not resolved and VISION BLURRED (blurred vision) and ARTHRALGIA (joints hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Blood pressure measurement: 6.11 left the hospital with a pressure of 6.11 but in the night it rose from 9 to 25.. On 25-Jan-2021, Computerised tomogram: normal. On 26-Jan-2021, Blood pressure measurement: 22 pressure went up to 22. On 27-Jan-2021, Blood pressure measurement: 23.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient take Medication for the pressure
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects; This spontaneous case was reported by a consumer and describes the occurrence of   in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain, Tachycardia, Vaccination site pain
Clinical narrative: pain injection site; aches all over her body; felt like I was hit by a truck; heart rate was faster than normal; This spontaneous case was reported by a consumer and describes the occurrence of   in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020. Concomitant products included METOPROLOL for Heart rate increased.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchy Sensation Near the Injection Site; Discomfort near injection site; Swelling near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Discomfort near injection site), VACCINATION SITE SWELLING (Swelling near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation Near the Injection Site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (Discomfort near injection site) and VACCINATION SITE SWELLING (Swelling near Injection Site). On 24-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy Sensation Near the Injection Site). At the time of the report, VACCINATION SITE DISCOMFORT (Discomfort near injection site), VACCINATION SITE SWELLING (Swelling near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation Near the Injection Site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: a rash on the back of her shoulders, from one to the other, painful, burning, not itchy; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (a rash on the back of her shoulders, from one to the other, painful, burning, not itchy) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032LC0A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included NABUMETONE (RELAFEN) and NABUMETONE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (a rash on the back of her shoulders, from one to the other, painful, burning, not itchy). On 24-Jan-2021, RASH (a rash on the back of her shoulders, from one to the other, painful, burning, not itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient take Solution of Witch-hazel and 3 Benadryl as a treatment medication
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Diagnosed with COVID; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Diagnosed with COVID) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID). At the time of the report, COVID-19 (Diagnosed with COVID) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema
Clinical narrative: right arm was a little sore the next day; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), MINERALS NOS, VITAMINS NOS (MULTIVITAMIN AND MINERAL SUPPLEMENT) and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Hives; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Hives) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included MULTI VITAMINS & MINERALS for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hives). The patient was treated with PREDNISONE at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and FAMOTIDINE (PEPCID AC) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE URTICARIA (Hives) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: red at near the injection site/red 3 inch wide; swollen; soreness; Itching around the arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching around the arm), VACCINATION SITE ERYTHEMA (red at near the injection site/red 3 inch wide), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Itching around the arm). On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at near the injection site/red 3 inch wide), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 22-Jan-2021, PRURITUS (Itching around the arm), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (red at near the injection site/red 3 inch wide) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive result for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive result for Covid) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced COVID-19 (Positive result for Covid). At the time of the report, COVID-19 (Positive result for Covid) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: injection site it was itchy; red and like a rush; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), VACCINATION SITE PRURITUS (injection site it was itchy) and VACCINATION SITE ERYTHEMA (red and like a rush) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). On 20-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site it was itchy) and VACCINATION SITE ERYTHEMA (red and like a rush). On 18-Jan-2021, PAIN IN EXTREMITY (sore left arm) outcome was unknown. On 24-Jan-2021, VACCINATION SITE PRURITUS (injection site it was itchy) and VACCINATION SITE ERYTHEMA (red and like a rush) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: arm is sore; swollen; red; itchy; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm is sore), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red), INJECTION SITE PRURITUS (itchy) and HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm is sore), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red), INJECTION SITE PRURITUS (itchy) and HEADACHE (headache). The patient was treated with Manual therapy (Ice packs) for Vaccination site pain; Manual therapy (Ice pack) for Vaccination site swelling; Manual therapy (Ice pack) for Vaccination site erythema and Manual therapy (Ice pack) for Injection site pruritus. At the time of the report, VACCINATION SITE PAIN (arm is sore), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red), INJECTION SITE PRURITUS (itchy) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Heart rate increased
Clinical narrative: Did not feel good; Dizzy; Weak; Fatigue; Muscle ache; Heart rate was 144; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel good), DIZZINESS (Dizzy), ASTHENIA (Weak), FATIGUE (Fatigue) and MYALGIA (Muscle ache) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concurrent medical conditions included Prediabetes. Concomitant products included METFORMIN for Prediabetes, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced MALAISE (Did not feel good), DIZZINESS (Dizzy), ASTHENIA (Weak), FATIGUE (Fatigue), MYALGIA (Muscle ache), HEART RATE INCREASED (Heart rate was 144) and HEADACHE (headache). At the time of the report, MALAISE (Did not feel good), DIZZINESS (Dizzy), ASTHENIA (Weak), FATIGUE (Fatigue), MYALGIA (Muscle ache), HEART RATE INCREASED (Heart rate was 144) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia
Clinical narrative: Did not feel good; Dizzy; Weak; Fatigue; Muscle ache; Heart rate was 144; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel good), DIZZINESS (Dizzy), ASTHENIA (Weak), FATIGUE (Fatigue) and MYALGIA (Muscle ache) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concurrent medical conditions included Prediabetes. Concomitant products included METFORMIN for Prediabetes, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced MALAISE (Did not feel good), DIZZINESS (Dizzy), ASTHENIA (Weak), FATIGUE (Fatigue), MYALGIA (Muscle ache), HEART RATE INCREASED (Heart rate was 144) and HEADACHE (headache). At the time of the report, MALAISE (Did not feel good), DIZZINESS (Dizzy), ASTHENIA (Weak), FATIGUE (Fatigue), MYALGIA (Muscle ache), HEART RATE INCREASED (Heart rate was 144) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vision blurred
Clinical narrative: eyes could not focus, they were "going around and around"; nauseous; whole body was achy; This spontaneous case was reported by a consumer and describes the occurrence of   in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Rash, Rash morbilliform
Clinical narrative: Measles looking like rash on torso; Rash on arm; Feeling tired; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH MORBILLIFORM (Measles looking like rash on torso), RASH (Rash on arm) and FATIGUE (Feeling tired) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced RASH MORBILLIFORM (Measles looking like rash on torso), RASH (Rash on arm) and FATIGUE (Feeling tired). At the time of the report, RASH MORBILLIFORM (Measles looking like rash on torso), RASH (Rash on arm) and FATIGUE (Feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: calling to register in the pregnancy registry after receiving the Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (calling to register in the pregnancy registry after receiving the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (calling to register in the pregnancy registry after receiving the Moderna vaccine). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (calling to register in the pregnancy registry after receiving the Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Pain in extremity, Rash, Rash erythematous
Clinical narrative: Red rash; hives; Very bad arm pain; Left armpit had pain; Could not lift arm; lef shoulder pain; Skin rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very bad arm pain), AXILLARY PAIN (Left armpit had pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm), RASH ERYTHEMATOUS (Red rash) and URTICARIA (hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH (Skin rash). On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Very bad arm pain), AXILLARY PAIN (Left armpit had pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm) and ARTHRALGIA (lef shoulder pain). On 23-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Red rash) and URTICARIA (hives). On 22-Jan-2021, RASH (Skin rash) had resolved. At the time of the report, PAIN IN EXTREMITY (Very bad arm pain), AXILLARY PAIN (Left armpit had pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm), RASH ERYTHEMATOUS (Red rash), URTICARIA (hives) and ARTHRALGIA (lef shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site movement impairment
Clinical narrative: Red rash; hives; Very bad arm pain; Left armpit had pain; Could not lift arm; lef shoulder pain; Skin rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very bad arm pain), AXILLARY PAIN (Left armpit had pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm), RASH ERYTHEMATOUS (Red rash) and URTICARIA (hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH (Skin rash). On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Very bad arm pain), AXILLARY PAIN (Left armpit had pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm) and ARTHRALGIA (lef shoulder pain). On 23-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Red rash) and URTICARIA (hives). On 22-Jan-2021, RASH (Skin rash) had resolved. At the time of the report, PAIN IN EXTREMITY (Very bad arm pain), AXILLARY PAIN (Left armpit had pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift arm), RASH ERYTHEMATOUS (Red rash), URTICARIA (hives) and ARTHRALGIA (lef shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discharge, Vaccination site pruritus, Vaccination site rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site rash (red rash in the injection site that spread all over her upper arm), vaccination site pruritus (arm is very itchy) and vaccination site discharge (arm looks splashy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011J20A) for COVID-19 immunization. No medical history provided. On Jan 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 11, 2021, patient experienced vaccination site rash (red rash in the injection site that spread all over her upper arm), vaccination site pruritus (arm is very itchy) and vaccination site discharge (arm looks splashy). At the time of the report, vaccination site rash (red rash in the injection site that spread all over her upper arm), vaccination site pruritus (arm is very itchy) and vaccination site discharge (arm looks splashy) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Injection area is rough; Injection area is red; Injection area is warm; Injection area is itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Injection area is rough), VACCINATION SITE ERYTHEMA (Injection area is red), VACCINATION SITE WARMTH (Injection area is warm) and VACCINATION SITE PRURITUS (Injection area is itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Injection area is rough), VACCINATION SITE ERYTHEMA (Injection area is red), VACCINATION SITE WARMTH (Injection area is warm) and VACCINATION SITE PRURITUS (Injection area is itchy). At the time of the report, VACCINATION SITE URTICARIA (Injection area is rough), VACCINATION SITE ERYTHEMA (Injection area is red), VACCINATION SITE WARMTH (Injection area is warm) and VACCINATION SITE PRURITUS (Injection area is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Swelling at the injection site; Pain under the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE PAIN (Pain under the injection arm) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE PAIN (Pain under the injection arm). At the time of the report, INJECTION SITE SWELLING (Swelling at the injection site) and INJECTION SITE PAIN (Pain under the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Pain in extremity, Vaccination site mass, Vaccination site pruritus, Vaccination site swelling, Vaccination site urticaria
Clinical narrative: arm was hurting up to  shoulder and neck area.; Area is feverish.; itches real bad; Huge welts; really swollen; bunch of knots at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (bunch of knots at the injection site), PAIN IN EXTREMITY (arm was hurting up to  shoulder and neck area.), VACCINATION SITE WARMTH (Area is feverish.), VACCINATION SITE PRURITUS (itches real bad) and VACCINATION SITE URTICARIA (Huge welts) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE MASS (bunch of knots at the injection site). On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting up to  shoulder and neck area.), VACCINATION SITE WARMTH (Area is feverish.), VACCINATION SITE PRURITUS (itches real bad), VACCINATION SITE URTICARIA (Huge welts) and VACCINATION SITE SWELLING (really swollen). On 25-Jan-2021, VACCINATION SITE PRURITUS (itches real bad) had resolved. At the time of the report, VACCINATION SITE MASS (bunch of knots at the injection site), PAIN IN EXTREMITY (arm was hurting up to  shoulder and neck area.), VACCINATION SITE WARMTH (Area is feverish.), VACCINATION SITE URTICARIA (Huge welts) and VACCINATION SITE SWELLING (really swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vaccination site warmth
Clinical narrative: arm was hurting up to  shoulder and neck area.; Area is feverish.; itches real bad; Huge welts; really swollen; bunch of knots at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (bunch of knots at the injection site), PAIN IN EXTREMITY (arm was hurting up to  shoulder and neck area.), VACCINATION SITE WARMTH (Area is feverish.), VACCINATION SITE PRURITUS (itches real bad) and VACCINATION SITE URTICARIA (Huge welts) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE MASS (bunch of knots at the injection site). On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting up to  shoulder and neck area.), VACCINATION SITE WARMTH (Area is feverish.), VACCINATION SITE PRURITUS (itches real bad), VACCINATION SITE URTICARIA (Huge welts) and VACCINATION SITE SWELLING (really swollen). On 25-Jan-2021, VACCINATION SITE PRURITUS (itches real bad) had resolved. At the time of the report, VACCINATION SITE MASS (bunch of knots at the injection site), PAIN IN EXTREMITY (arm was hurting up to  shoulder and neck area.), VACCINATION SITE WARMTH (Area is feverish.), VACCINATION SITE URTICARIA (Huge welts) and VACCINATION SITE SWELLING (really swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pruritus, Urticaria
Clinical narrative: Breaking out with hives; Super itchy; sore arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of URTICARIA (Breaking out with hives), PRURITUS (Super itchy) and ARTHRALGIA (sore arm) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ARTHRALGIA (sore arm). On 21-Jan-2021, the patient experienced URTICARIA (Breaking out with hives) and PRURITUS (Super itchy). At the time of the report, URTICARIA (Breaking out with hives), PRURITUS (Super itchy) and ARTHRALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Influenza like illness, Nausea
Clinical narrative: mild flu-like symptoms; diarrhea; loss of appetite; vomiting; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting) and NAUSEA (nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037H201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (fatigue). On 20-Jan-2021, INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: mild flu-like symptoms; diarrhea; loss of appetite; vomiting; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting) and NAUSEA (nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037H201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (fatigue). On 20-Jan-2021, INFLUENZA LIKE ILLNESS (mild flu-like symptoms), DIARRHOEA (diarrhea), DECREASED APPETITE (loss of appetite), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site oedema
Clinical narrative: edema at injection site; Erythema at injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE OEDEMA (edema at injection site) and VACCINATION SITE ERYTHEMA (Erythema at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE OEDEMA (edema at injection site) and VACCINATION SITE ERYTHEMA (Erythema at injection site). On 12-Jan-2021, VACCINATION SITE OEDEMA (edema at injection site) and VACCINATION SITE ERYTHEMA (Erythema at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itching; Rash that goes from the top that extends down little below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching) and VACCINATION SITE RASH (Rash that goes from the top that extends down little below the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching) and VACCINATION SITE RASH (Rash that goes from the top that extends down little below the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching) and VACCINATION SITE RASH (Rash that goes from the top that extends down little below the injection site) had not resolved. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This spontaneous case was reported by an other caregiver and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm). At the time of the report, PERIPHERAL SWELLING (swollen arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.